These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 20599527)

  • 1. Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax.
    Kheradmandnia S; Vasheghani-Farahani E; Nosrati M; Atyabi F
    Nanomedicine; 2010 Dec; 6(6):753-9. PubMed ID: 20599527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of drug release from nanocarriers loaded with a poorly water soluble drug (flurbiprofen) comprising natural waxes.
    Baviskar DT; Amritkar AS; Chaudhari HS; Jain DK
    Pharmazie; 2012 Aug; 67(8):701-5. PubMed ID: 22957435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
    Kumar R; Singh A; Garg N; Siril PF
    Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of carnauba wax nanostructured lipid carriers containing benzophenone-3.
    Lacerda SP; Cerize NN; Ré MI
    Int J Cosmet Sci; 2011 Aug; 33(4):312-21. PubMed ID: 21284656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid.
    Lim SJ; Kim CK
    Int J Pharm; 2002 Aug; 243(1-2):135-46. PubMed ID: 12176302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and stability of nanostructured lipid carriers as drug delivery system.
    Abbasalipourkabir R; Salehzadeh A; Abdullah R
    Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K; Reddy H; Murthy RS
    AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Lipid-Surfactant Miscibility for the Development of Solid Lipid Nanoparticles.
    Trivino A; Gumireddy A; Chauhan H
    AAPS PharmSciTech; 2019 Jan; 20(2):46. PubMed ID: 30617602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of all-trans retinol by loading lipophilic antioxidants in solid lipid nanoparticles.
    Jee JP; Lim SJ; Park JS; Kim CK
    Eur J Pharm Biopharm; 2006 Jun; 63(2):134-9. PubMed ID: 16527470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables.
    Das S; Ng WK; Kanaujia P; Kim S; Tan RB
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):483-9. PubMed ID: 21831615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, Characterization and Anti-Ulcer Efficacy of Sanguinarine Loaded Solid Lipid Nanoparticles.
    Sun Q; Li W; Li H; Wang X; Wang Y; Niu X
    Pharmacology; 2017; 100(1-2):14-24. PubMed ID: 28334726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system.
    Chalikwar SS; Belgamwar VS; Talele VR; Surana SJ; Patil MU
    Colloids Surf B Biointerfaces; 2012 Sep; 97():109-16. PubMed ID: 22609590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of coenzyme Q10 loaded solid lipid nanoparticle hydrogel for enhanced dermal delivery.
    Korkm E; Gokce EH; Ozer O
    Acta Pharm; 2013 Dec; 63(4):517-29. PubMed ID: 24451076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical gel of Metformin solid lipid nanoparticles: A hopeful promise as a dermal delivery system.
    Rostamkalaei SS; Akbari J; Saeedi M; Morteza-Semnani K; Nokhodchi A
    Colloids Surf B Biointerfaces; 2019 Mar; 175():150-157. PubMed ID: 30530000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic approach for the formulation and optimization of atorvastatin loaded solid lipid NANOAPARTICLES using response surface methodology.
    Sarangi B; Jana U; Sahoo J; Mohanta GP; Manna PK
    Biomed Microdevices; 2018 Jun; 20(3):53. PubMed ID: 29946758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.